Oncology Medications Policy

eviCore covers FDA‑approved drugs for direct cancer treatment and specified supportive‑care classes when used per NCCN Guidelines (Categories 1, 2A, 2B) or the FDA indication, with a set of specifically listed agents (e.g., select hormonal agents, oral antimetabolites, certain corticosteroids, NSAIDs, some antimicrobials, common antiemetics, alendronate, pamidronate) exempt from prior authorization. Key requirements: most oncology drugs and supportive‑class drugs require prior authorization and documentation demonstrating NCCN/FDA‑aligned use; non‑cancer uses and all hematopoietic stem cell transplantation‑related uses are excluded.

"Myeloid Growth Factors: No exempted medications (i."

Sign up to see full coverage criteria, indications, and limitations.